TAFRO Syndrome and Elusive Diagnosis of Idiopathic Multicentric Castleman Disease Treated with Empiric Anti-Interleukin-6 Therapy
TAFRO syndrome is defined by the presence of thrombocytopenia (T), anasarca (A), fever (F), reticulin fibrosis/renal dysfunction (R), and organomegaly (O) and can be seen with idiopathic multicentric Castleman disease (iMCD) or as an isolated process without iMCD. Although the diagnosis of iMCD in p...
Main Authors: | Corinne Williams, Alexis Phillips, Vikram Aggarwal, Liron Barnea Slonim, David C. Fajgenbaum, Reem Karmali |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-09-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/518079 |
Similar Items
-
Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine
by: Christian Hoffmann, et al.
Published: (2022-10-01) -
TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
by: Kazue Takai
Published: (2024-03-01) -
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences
by: Bernardo Rossini, et al.
Published: (2024-03-01) -
TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature
by: Céline Louis, et al.
Published: (2017-09-01) -
A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome
by: Ece Ük, et al.
Published: (2022-08-01)